Cargando…
Recurrent Fusion Genes in Leukemia: An Attractive Target for Diagnosis and Treatment
INTRODUCTION: Since the first fusion gene was discovered decades ago, a considerable number of fusion genes have been detected in leukemia. The majority of them are generated through chromosomal rearrangement or abnormal transcription. With the development of techniques, high-throughput sequencing m...
Autores principales: | Wang, Yuhui, Wu, Nan, Liu, Duo, Jin, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635644/ https://www.ncbi.nlm.nih.gov/pubmed/29081694 http://dx.doi.org/10.2174/1389202918666170329110349 |
Ejemplares similares
-
Targeting Glutamine Metabolism as an Attractive Therapeutic Strategy for Acute Myeloid Leukemia
por: Xiao, Yan, et al.
Publicado: (2023) -
Inflammatory Cytokine: An Attractive Target for Cancer Treatment
por: Lee, Hyang-Mi, et al.
Publicado: (2022) -
Prognostic and therapeutic role of targetable lesions in B-lineage acute lymphoblastic leukemia without recurrent fusion genes
por: Messina, Monica, et al.
Publicado: (2016) -
Fusion genes in solid tumors: an emerging target for cancer diagnosis and treatment
por: Parker, Brittany C., et al.
Publicado: (2013) -
Integrins as attractive targets for cancer therapeutics
por: Li, Meng, et al.
Publicado: (2021)